Skip to main content

REVIEW article

Front. Oncol.

Sec. Cancer Metabolism

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1530567

The lactylation modification of proteins plays a critical role in tumor progression

Provisionally accepted
Dehao Yi Dehao Yi 1Ke Zhou Ke Zhou 2Pan Yinlong Pan Yinlong 1huazhong Cai huazhong Cai 1*Pan Huang Pan Huang 2*
  • 1 Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China
  • 2 School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China

The final, formatted version of the article will be published soon.

    Lactylation modifications have been shown to be a novel type of protein post-translational modifications (PTMs), providing a new perspective for understanding the interaction between cellular metabolic reprogramming and epigenetic regulation. Studies have shown that lactylation plays an important role in the occurrence, development, angiogenesis, invasion and metastasis of tumors. It can not only regulate the phenotypic expression and functional polarization of immune cells, but also participate in the formation of tumor drug resistance through a variety of molecular mechanisms. In this review, we review the latest research progress of lactylation modification in tumors, focusing on its mechanism of action in angiogenesis, immune cell regulation in tumor microenvironment (TME), and tumor drug resistance, aiming to provide a theoretical basis and research ideas for the discovery of new therapeutic targets and methods. Through the in-depth analysis of lactylation modification, it is expected to open up a new research direction for tumor treatment and provide potential strategies for overcoming tumor drug resistance and improving clinical efficacy.

    Keywords: lactylation modification, tumor, Angiogenesis, Drug Resistance, TME Warburg effect and lactylation

    Received: 01 Jan 2025; Accepted: 04 Mar 2025.

    Copyright: © 2025 Yi, Zhou, Yinlong, Cai and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    huazhong Cai, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China
    Pan Huang, School of Medicine, Jiangsu University, Zhenjiang, 2012013, Jiangsu Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more